Quality Improvement Project for Maternal Health and Family Planning Services in Kenya (SPARQ_QIK)

Strengthening People-centered Accessibility, Respect, and Quality for Maternal Health and Family Planning Services in Nairobi, Kenya

Evaluation of a quality improvement (QI) collaborative aimed at improving person-centered care (PCC) for maternal health (MH) and family planning (FP) services

Study Overview

• Status: Completed
• Conditions: Maternal Health; Family Planning; Delivery
• Intervention / Treatment: Behavioral: Quality Improvement Collaborative

Detailed Description

Evaluation of a quality improvement (QI) collaborative in public facilities in Nairobi and Kiambu Counties in Kenya aimed at improving person-centered care (PCC) for maternal health (MH) and family planning (FP) services.

• Study Type: Interventional
• Enrollment (Actual): 3354
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Kenya
  • Nairobi, Kenya
    • Innovations for Poverty Action

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 15 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria for Women:

• Women aged 15-49 years old
• Agreed/consented to participate
• Delivered at the facility within the last 7 days OR adopted a family planning method at their visit on day of survey
• Has a working mobile phone and specified service provider (airtel/safaricom)

Exclusion Criteria for Women:

• Not a women aged 15-49 years old
• Did no agreed/consented to participate
• Did not deliver at the facility within the last 7 days OR adopted a family planning method at their visit on day of survey
• Does not have a working mobile phone or specified service provider (airtel/safaricom)

Inclusion Criteria for Providers:

• Agreed/consented to participate
• Staff at facility

Exclusion Criteria for Providers

• Did no agreed/consent to participate
• Not staff at facility

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control - Women; Participants who delivered or received family planning services at a facility that was not implementing a QI project on PCC
Experimental: Intervention - Women; Participants who delivered or received family planning services at a facility that was implementing a QI project on PCC	Behavioral: Quality Improvement Collaborative; Facilities that participated in a QI collaborative to improve PCC for MH and FP services
No Intervention: Control - Provider; Provider working in a facility that is not implementing a QI project on PCC
Experimental: Intervention - Provider; Provider working in a facility that is implementing a QI project on PCC	Behavioral: Quality Improvement Collaborative; Facilities that participated in a QI collaborative to improve PCC for MH and FP services

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	Baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	2-weeks post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	4-weeks post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	6-weeks post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	10-weeks post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	About 24 months post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	About 26 months post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	About 30 months post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	About 30.5 months post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	about 31 months post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	31.5 months post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	32 months post baseline
Person Centered Maternal Health Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-100; higher the score the better the experience of care	32.5 months post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	Baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	4 weeks post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	6 weeks post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	8 weeks post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	10 weeks post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	About 24 months post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	About 26 months post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	About 30 months post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	About 31 months post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	About 31.5 months post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	About 32 months post baseline
Person Centered Family Planning Scale Score	Survey conducted with women: self report of experiences of care. Possible range 0-43; higher the score the better the experience of care	About 32.5 months post baseline
Attitudes toward Person-Centered Care	Survey and In-depth interviews conducted with providers; perceptions of person-centered care	Baseline
Attitudes toward Person-Centered Care	Survey conducted with providers; perceptions of person-centered care	About 24 months post baseline
Attitudes toward Person-Centered Care	Survey conducted with providers; perceptions of person-centered care	About 26 months post baseline
Attitudes toward Person-Centered Care	Survey and In-depth interviews conducted with providers; perceptions of person-centered care	About 30 months post baseline
The Model for Understanding Success in Quality Survey	Survey conducted with intervention providers on facility readiness to implement QI; Possible range 0-154; higher the score the more ready facility is to participate in QI activities	About 30 months post baseline

Collaborators and Investigators

• Sponsor: University of California, San Francisco
• Collaborators: Innovations for Poverty Action
• Investigators: Principal Investigator: Dominic Montagu, DrPH, University of California, San Francisco

Study record dates

Study Major Dates

• Study Start (Actual): August 8, 2016
• Primary Completion (Actual): April 12, 2019
• Study Completion (Actual): April 12, 2019

Study Registration Dates

• First Submitted: December 19, 2019
• First Submitted That Met QC Criteria: December 19, 2019
• First Posted (Actual): December 23, 2019

Study Record Updates

• Last Update Posted (Actual): December 23, 2019
• Last Update Submitted That Met QC Criteria: December 19, 2019
• Last Verified: December 1, 2019

More Information

Terms related to this study

• Keywords: Kenya; Delivery; Quality Improvement; Maternal Health; Family Planning; Person Centered Care
• Other Study ID Numbers: 15-18008_KenyaQI

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No